I don't think ATH is involved in any FA trial at the moment. Chances are Ashley Pall got interested in the research. She still appears as a PhD student on the Wayne State University website. It appears we have many collaborators and the wonder molecule continues to gain traction in the neurodegenerative disorder space. It's gonna be interesting to know what her findings are. Good news.
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress, page-18
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $3.446K | 695K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 80636710 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 19070116 | 14 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 537000 | ||
| Last updated 14.20pm 13/06/2024 ? | |||||
| ATH (ASX) Chart |